Arbor Biotechnologies to Present at 2023 Cell & Gene Meeting on the Med
06 avr. 2023 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that Devyn...
Arbor Biotechnologies Announces Expanded Strategic Partnership with Vertex, Now Extending to Precision Gene Editing Using Reverse Transcriptase
11 janv. 2023 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor) today announced the expansion of an existing strategic collaboration covering in vivo genetic medicines by which...
Arbor Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 janv. 2023 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief...
Arbor Biotechnologies’ CEO Devyn Smith, Ph.D., Elected as Chairman of the Alliance for Regenerative Medicine
20 oct. 2022 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief...
Arbor Biotechnologies to Participate in the 2022 Cell & Gene Meeting on the Mesa
04 oct. 2022 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that senior...
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
22 sept. 2022 16h01 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
Arbor Biotechnologies Named One of Fierce Biotech’s “Fierce 15” Companies of 2022
12 sept. 2022 08h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies today announced that Fierce Biotech has named it as one of 2022’s “Fierce 15” biotechnology companies, designating it as...
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
01 sept. 2022 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases
25 août 2022 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that it has...
Arbor Biotechnologies Appoints Lee Ann Marchionna as Chief People Officer
02 août 2022 07h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...